title: [Surgical management of renal hyperparathyroidism].
abstract: Conservative management of renal hyperparathyroidism has changed recently. Innovative substances, especially the advent of calcimimetics, have influenced the therapeutic concept. Consequently, a decline in surgical frequency for renal hyperparathyroidism has been reported. In this context it is now mandatory to evaluate the role of surgery, the surgical strategy and procedures for renal hyperparathyroidism anew. Based on a review of the literature the current position of surgical indications and care for renal hyperparathyroidism as well as possible influences of innovative medical treatment are highlighted. In summary, the timing and indications for surgery have been influenced, however, surgery still remains the only permanently effective treatment option for renal hyperparathyroidism.
authors.affiliation: Martin-Luther Universität Halle-Wittenberg, Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Halle / Saale, Deutschland.
authors.forename: K
authors.initials: K
authors.lastname: Lorenz
authors.affiliation: Martin-Luther Universität Halle-Wittenberg, Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Halle / Saale, Deutschland.
authors.forename: C
authors.initials: C
authors.lastname: Sekulla
authors.affiliation: Martin-Luther Universität Halle-Wittenberg, Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Halle / Saale, Deutschland.
authors.forename: H
authors.initials: H
authors.lastname: Dralle
mesh_terms: D064592:Autografts; D057966:Calcimimetic Agents / Q000627:therapeutic use; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery*; D004359:Drug Therapy, Combination; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery*; D016030:Kidney Transplantation; D010280:Parathyroid Glands / Q000637:transplantation; D010281:Parathyroid Hormone / Q000097:blood; D016105:Parathyroidectomy / Q000379:methods*; D011183:Postoperative Complications / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D011300:Preoperative Care / Q000379:methods; D012008:Recurrence; D012307:Risk Factors
chemical_list: D057966:Calcimimetic Agents; D010281:Parathyroid Hormone